Scientific Opinion on the substantiation of a health claim related to Cynatine<sup>®</sup> and maintenance of normal joint mobility pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Scientific Opinion on the substantiation of a health claim related to Cynatine<sup>®</sup> and maintenance of normal joint mobility pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from Roxlor Nutra LLC, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim...

وصف كامل

التفاصيل البيبلوغرافية
المؤلف الرئيسي: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
التنسيق: مقال
اللغة:English
منشور في: Wiley 2012-12-01
سلاسل:EFSA Journal
الموضوعات:
Cynatine®
joints
mobility
osteoarthritis
chronic inflammation
health claims
الوصول للمادة أونلاين:http://www.efsa.europa.eu/en/efsajournal/doc/3004.pdf

الانترنت

http://www.efsa.europa.eu/en/efsajournal/doc/3004.pdf

مواد مشابهة